Describes the use of PET/CT in malignancies of the hepatobiliary system and pancreas Considers the role of other imaging modalities in these malignancies

Includes information on epidemiology, clinical presentation, pathology, staging, and management

Explains concepts with the aid of high-quality illustrations

Autorentext
Nilendu Purandare is an Associate Professor and Consultant Radiologist in the Department of Nuclear Medicine and Molecular Imaging at the Tata Memorial Cancer Centre, which is a tertiary referral cancer centre in Mumbai affiliated to the Homi Bhabha National University. Dr. Purandare received his degree in Medicine from Mumbai University and subsequently completed residency training in Radiology at Tata Memorial Hospital. He has been working in PET/CT since 2004 and is interested in hybrid imaging techniques combining diagnostic CT protocols with FDG PET. He has published on PET/CT in peer-reviewed national and international journals.

Sneha Shah is an Associate Professor in Nuclear Medicine in the Department of Nuclear Medicine and Molecular Imaging at Tata Memorial Hospital, Mumbai, India, which is a tertiary oncology institute. She completed her nuclear medicine residency at the Radiation Medicine Centre, Mumbai and PD Hinduja National Hospital, Mumbai and subsequently received training in the use of PET/CT in oncology at Tata Memorial Hospital. She has expertise in the performance of PET/CT using FDG and several other non-FDG PET tracers and has a keen interest in radionuclide therapy.

Inhalt
Hepatobiliary and Pancreatic Malignancies: Epidemiology, Clinical Presentation, Diagnosis, Staging.- Pathology of Hepatobiliary and Pancreatic Cancer.- Management of Hepatobiliary and Pancreatic Malignancies.- Radiological Imaging in Hepatobiliary and Pancreatic Malignancies.- 18F-FDG PET/CT: Normal Variants, Artifacts and Pitfalls in Hepatobiliary and Pancreatic Malignancies.- PET/CT in Hepatic Malignancies.- PET/CT in Pancreatic Malignancies.- PET/CT in Gall Bladder and Biliary Tract Malignancies.